Liu Qiaoling, Celis-Morales Carlos, Lees Jennifer S, Sattar Naveed, Ho Frederick K, Pell Jill P, Mark Patrick B, Welsh Paul
School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom.
Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.
Clin Chem. 2025 Aug 1;71(8):858-869. doi: 10.1093/clinchem/hvaf063.
The consequences for health outcomes of the discordance in cystatin C-based (eGFRcys) and creatinine-based (eGFRcr) estimated glomerular filtration rates are gaining attention. However, the association of discordance with all-cause mortality in the general population has not been explored.
A total of 325 356 UK Biobank participants, 40 to 69 years of age, were followed for a median of 13.7 years. eGFR was calculated using both the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2009/2012 equations and the European Kidney Function Consortium (EKFC) equations. Differences were expressed as the absolute difference (eGFRcys - eGFRcr, where discordance was defined as ±15 mL/min/1.73 m2 difference) and relative difference (eGFRcys/eGFRcr, where discordance was defined as eGFRcys < 60% eGFRcr). Hazard ratios (HRs) for mortality were estimated using multivariable Cox proportional hazards models.
Among the participants, 15.5% had a discordant lower absolute eGFRcys, and 8.5% had a discordant higher absolute eGFRcys. Participants with discordant lower absolute eGFRcys (both CKD-EPI and EKFC equations) were older, more frequently male, had higher body mass index (BMI) and blood pressure, more comorbidities, and did less physical activity. A total of 26 465 deaths occurred. Participants with discordant lower eGFRcys had a 53% higher risk of mortality (HR = 1.53: 95% CI, 1.48-1.57), while those with discordant higher eGFRcys had a 30% lower risk (HR = 0.70: 95% CI, 0.66-0.75) compared to those with concordant eGFR. Those with discordance of lower relative eGFRcys had doubled risk of mortality (HR = 2.25: 95% CI, 2.04-2.47).
eGFR discordance was prevalent and associated with mortality in general populations. These results support broader use of cystatin C for risk stratification of mortality.
基于胱抑素C的估算肾小球滤过率(eGFRcys)与基于肌酐的估算肾小球滤过率(eGFRcr)不一致对健康结局的影响正受到关注。然而,一般人群中这种不一致与全因死亡率的关联尚未得到探讨。
对英国生物银行中325356名年龄在40至69岁之间的参与者进行了为期13.7年的中位数随访。使用慢性肾脏病流行病学协作组(CKD-EPI)2009/2012方程和欧洲肾功能联盟(EKFC)方程计算eGFR。差异以绝对差值(eGFRcys - eGFRcr,不一致定义为差值±15 mL/min/1.73 m2)和相对差值(eGFRcys/eGFRcr,不一致定义为eGFRcys < 60% eGFRcr)表示。使用多变量Cox比例风险模型估计死亡率的风险比(HR)。
在参与者中,15.5%的人绝对eGFRcys较低且不一致,8.5%的人绝对eGFRcys较高且不一致。绝对eGFRcys较低且不一致的参与者(CKD-EPI和EKFC方程均如此)年龄更大,男性更常见,体重指数(BMI)和血压更高,合并症更多,身体活动更少。共发生26465例死亡。与eGFR一致的参与者相比,绝对eGFRcys较低且不一致的参与者死亡风险高53%(HR = 1.53:95%CI,1.48 - 1.57),而绝对eGFRcys较高且不一致的参与者死亡风险低30%(HR = 0.70:95%CI,0.66 - 0.75)。相对eGFRcys较低且不一致的参与者死亡风险增加一倍(HR = 2.25:95%CI,2.04 - 2.47)。
eGFR不一致在一般人群中普遍存在且与死亡率相关。这些结果支持更广泛地使用胱抑素C进行死亡风险分层。